Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
Holdings in Q2 2024
Holdings as of Jun 30, 2024, filed Aug 9, 2024. Long positions only; changes compare share counts with Q1 2024.
- Positions
- 20
- −2 vs. Q1 2024
- Portfolio value
- $400.7M
- −$4.01B (−90.9%) vs. Q1 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PTGXProtagonist Therapeutics, Inc | COM | 2,449,183 | $84.9M | 21.2% | 00.0% | Unchanged | History |
| RAPPRapport Therapeutics, Inc. | COM | 2,498,051 | $58.1M | 14.5% | +2,498,051 | New | History |
| CVRXCVRx, Inc. | COM | 4,103,430 | $49.2M | 12.3% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 814,586 | $36.1M | 9.0% | 00.0% | Unchanged | History |
| CTNMContineum Therapeutics, Inc. | CL A | 1,979,173 | $34.9M | 8.7% | +1,979,173 | New | History |
| NBTXNanobiotix S.A. | SPONSORED ADS | 5,623,816 | $28.1M | 7.0% | 00.0% | Unchanged | History |
| MGTXMeiraGTx Holdings plc | COM | 6,641,064 | $28.0M | 7.0% | 00.0% | Unchanged | History |
| PRCTPROCEPT BioRobotics Corp | COM | 357,939 | $21.9M | 5.5% | 00.0% | Unchanged | History |
| NMRANeumora Therapeutics, Inc. | COM | 1,849,445 | $18.2M | 4.5% | 00.0% | Unchanged | History |
| XNCRXencor Inc | COM | 748,062 | $14.2M | 3.5% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 3,379,064 | $11.1M | 2.8% | 00.0% | Unchanged | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 247,598 | $6.44M | 1.6% | 00.0% | Unchanged | History |
| RLYBRallybio Corp | COM | 3,636,363 | $4.87M | 1.2% | +3,636,363 | New | History |
| NNOXNano-X Imaging Ltd. | ORD SHS | 158,852 | $1.17M | 0.3% | 00.0% | Unchanged | History |
| VORVor Biopharma Inc. | COM | 1,074,658 | $1.07M | 0.3% | 00.0% | Unchanged | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 299,669 | $991.9K | 0.2% | 00.0% | Unchanged | History |
| HLSQTessera Defense & Homeland Security Inc. | COM | 1,923,201 | $646.4K | 0.2% | 00.0% | Unchanged | History |
| LABStandard Biotools Inc. | COM | 311,967 | $552.2K | 0.1% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM | 364,472 | $441.0K | 0.1% | 00.0% | Unchanged | History |
| SENSSenseonics Holdings, Inc. | COM | 54,621 | $21.8K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2024 (5)
Positions held at the end of Q1 2024 that are gone from this filing.
| Security | Class | Shares in Q1 2024 | Value in Q1 2024 | % of portfolio in Q1 2024 | History |
|---|---|---|---|---|---|
| KVUEKenvue Inc. | Stock | 182,329,550 | $3.91B | 88.7% | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 3,670,516 | $78.3M | 1.8% | History |
| SWAVShockwave Medical, Inc. | COM | 166,812 | $54.3M | 1.2% | History |
| CLSDClearside Biomedical, Inc. | COM | 169,629 | $259.5K | <0.1% | History |
| TCONTracon Pharmaceuticals, Inc. | COM NEW | 84,003 | $36.1K | <0.1% | History |